[Pathogenetically oriented therapy approaches in the treatment of chronic polyarthritis].
Krüger
K
K
Medizinische Poliklinik, Universität München.
Schattenkirchner
M
M
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000209:etiology / Q000628:therapy*; D001685:Biological Factors / Q000627:therapeutic use; D003524:Cyclosporins / Q000627:therapeutic use; D016207:Cytokines; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007937:Leukapheresis
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D001685:Biological Factors; D003524:Cyclosporins; D016207:Cytokines; D007166:Immunosuppressive Agents
Pathogenetisch orientierte Therapieansätze in der Behandlung der chronischen Polyarthritis.